Table of Contents
What changed
FY25 total income rose 80.2% to $48.2m and NPAT more than doubled to $40.8m from $19.9m, with PBT up 104.9% to $40.8m. Operating cash inflow rose 74.4% to $39.0m and cash on hand more than tripled to $15.3m. The balance sheet is almost debt-free: total liabilities fell to $0.7m against equity of $469.9m, with total assets of $470.6m still dominated by investments at fair value through P&L ($454.2m). The declared final dividend lifted to 2.75 cents per share from 2.65 cents.
What matters
- The FY25 result is an HY25 result. HY25 NPAT was $42.8m, implying H2 NPAT of roughly –$2.0m on just $1.8m of H2 revenue (96.3% of full-year revenue was booked in H1). For a listed investment company, this is mark-to-market reversal in the second half, not operating deterioration, but it materially changes the read on momentum.
- Earnings are portfolio-driven, not operational. With effective tax rates of 0.05% (FY25) and 0.12% (FY24), and income sourced through fair-value movements on investments, PBT growth of 104.9% is the same story as NPAT growth of 105.0%. ROE improved to 8.7% from 4.4%, but this is portfolio performance passed through to shareholders rather than operating leverage.
- Balance sheet strengthened at the margin. Equity grew $12.3m to $469.9m, broadly the sum of retained portfolio gains net of distributions. Leverage remains negligible.
Expectations
No forward targets, guidance, or NTA disclosure were supplied. The only shape context is HY25, which shows the full-year outcome was effectively locked in by the interim and then partially reversed. The release does not support a view that the second-half reversal is either transitory or structural — it simply reflects market movements over the second six months. Absent portfolio commentary on drivers, the $1.8m H2 revenue and –$2.0m H2 NPAT are the cleanest read on recent fund performance.
Quality of result
For an investment vehicle of this type, "quality" is best read as the durability of realised versus unrealised gains, which is not separately disclosed here. The cash picture is consistent with the P&L: operating cash flow of $39.0m mostly came in H2 ($28.8m implied), reflecting the timing of dividend receipts and portfolio rebalancing rather than earnings recognition. The dividend payout ratio fell to 23.1% of NPAT from 44.5%, but that is a function of NPAT more than doubling rather than any change in distribution policy — the DPS only rose 3.8%. Receivable days improved slightly to 8.3 from 9.2. There are no non-recurring items or non-GAAP adjustments to reconcile.
Unresolved
- Split between realised and unrealised gains within the $48.2m income line, and the H2 mark-to-market movements by holding.
- NTA per share and shares on issue at balance date, which would anchor the payout and the premium/discount discussion.
- Whether H2 weakness has continued into the new financial year, and any manager commentary on positioning.
- Management fee and performance fee accruals, and any buy-back or capital management activity contributing to the $28.5m of financing outflows implied between OCF and the cash movement.
This briefing cannot assess portfolio composition, benchmark-relative performance, or the premium or discount to NTA at which KFL shares currently trade.
Key metrics
| Metric | FY25 | FY24 | Change |
|---|---|---|---|
| Revenue | $48.2m | $26.8m | +80.2% ↑ |
| Net profit after tax | $40.8m | $19.9m | +105.0% ↑ |
| Net cash inflow from operating activities | $39.0m | $22.4m | +74.4% ↑ |
| Final dividend per share | 2.8c | 2.6c | +3.8% ↑ |
| Profit before tax | $40.8m | $19.9m | +104.9% ↑ |
| Cash and cash equivalents | $15.3m | $4.9m | +213.9% ↑ |
| Total assets | $470.6m | $458.9m | +2.6% ↑ |
Reference: annolyse.ai/briefings/kfl-fy25
Analytical metrics
| Metric | FY25 | FY24 | Context |
|---|---|---|---|
| PBT growth | +104.9% | — | — |
| Effective tax rate | 0.1% | 0.1% | — |
| Debtor days | 8.3 | 9.2 | -0.9 days |
| Payout ratio vs NPAT | 23.1% | — | — |
| ROE (annualised) | 8.7% | 4.3% | Strengthening |
| HY25 share of FY25 revenue | 96.3% | — | Other half was 3.7% |
| HY25 share of FY25 NPAT | 104.8% | — | Other half was -4.8% |
Reference: annolyse.ai/briefings/kfl-fy25
This analysis was generated using Annolyse, an AI-powered tool that analyses NZX company announcements. The analysis is based on available company filings and standard Annolyse calculations. This is general information only and does not constitute financial advice. The analysis may contain errors. Always read the original company filings and consult a licensed financial adviser before making investment decisions.